Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically
heterogeneous disease, and its incidence is increasing as the population ages …

Acute myeloid leukaemia is the most common form of acute leukaemia, and its incidence
increases with age. The disease derives from a transformed multipotent malignant …

With rapid scientific advances in human genomics, proteomics, experimental therapeutics,
and bioinformatics, the ability to optimize therapy for acute myelogenous leukemia (AML) …

Simple Summary Acute myeloid leukemia (AML) accounts for 7.6% of hematopoietic
malignancies with a long-term survival of less than 20%. Better understanding its …

Acute myeloid leukemia (AML) is the most frequently diagnosed acute leukemia, and its
incidence increases with age. Although the etiology of AML remains unknown, exposure to …

In recent years, research in genomics has resulted in the rapid uncovering of the molecular
pathogenesis of acute myeloid leukemia (AML). The identification of the genetic …

The significant progress in the treatment of acute lymphoblastic leukemia (ALL) experienced
over the last 3 decades has been driven mainly by the empirical combination of antileukemic …

Through the hard work of a large number of investigators, the biology of acute myeloid
leukemia (AML) is becoming increasingly well understood, and as a consequence, new …

Acute myeloid leukaemia (AML) is a malignant disorder of the myeloid blood lineage
characterized by impaired differentiation and increased proliferation of hematopoietic …

Acute myeloid leukemia (AML) is the most common form of acute leukemia, with an
incidence that increases with advanced age. Although it is usually of unknown etiology, it …